973 results on '"Kosuge, Tomoo"'
Search Results
2. Delayed Gastric Emptying After Stapled Versus Hand-Sewn Anastomosis of Duodenojejunostomy in Pylorus-Preserving Pancreaticoduodenectomy: a Randomized Controlled trial
3. Pancreatic neuroendocrine tumors: A single-center 20-year experience with 100 patients
4. Supplementary Tables 1-2 from Reduced Plasma Level of CXC Chemokine Ligand 7 in Patients with Pancreatic Cancer
5. Data from Identification of Adipophilin as a Potential Plasma Biomarker for Colorectal Cancer Using Label-Free Quantitative Mass Spectrometry and Protein Microarray
6. Supplementary Data from Expression and Gene Amplification of Actinin-4 in Invasive Ductal Carcinoma of the Pancreas
7. Supplementary Figures 1-3 from Reduced Plasma Level of CXC Chemokine Ligand 7 in Patients with Pancreatic Cancer
8. Supplementary Data Table 1 from Prognostic Value of Tumor Architecture, Tumor-Associated Vascular Characteristics, and Expression of Angiogenic Molecules in Pancreatic Endocrine Tumors
9. Supplementary Data from Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma
10. Supplementary Figure 1, Table 1 from Identification of Adipophilin as a Potential Plasma Biomarker for Colorectal Cancer Using Label-Free Quantitative Mass Spectrometry and Protein Microarray
11. Supplementary Data Figure 1 from Prognostic Value of Tumor Architecture, Tumor-Associated Vascular Characteristics, and Expression of Angiogenic Molecules in Pancreatic Endocrine Tumors
12. Supplementary Figure 1 from CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
13. Data from CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
14. Supplementary Table 1 from CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
15. Supplementary Figure 5 from CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
16. Supplementary Figure 3 from CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
17. Supplementary Figure 6 from CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
18. Supplementary Figure 4 from CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
19. Supplementary Table 2 from CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
20. Supplementary Figure 2 from CUB Domain–Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
21. Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial
22. Pancreas-sparing duodenectomy for gastrointestinal stromal tumor
23. PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors
24. Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma
25. The type of preoperative biliary drainage predicts short-term outcome after major hepatectomy
26. New Portal-Superior Mesenteric Vein Reconstructions Using First Jejunal Vein Flap in Pancreaticoduodenectomy
27. A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status
28. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer?
29. Genomic spectra of biliary tract cancer
30. Optimal Indications for Additional Resection of the Invasive Cancer-Positive Proximal Bile Duct Margin in Cases of Advanced Perihilar Cholangiocarcinoma
31. Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapy
32. Prognostic impact of marginal resection for patients with solitary hepatocellular carcinoma: Evidence from 570 hepatectomies
33. Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma
34. Is celiac axis resection justified for T4 pancreatic body cancer?
35. Analysis of Risk Factors for Delayed Gastric Emptying (DGE) after 387 Pancreaticoduodenectomies with Usage of 70 Stapled Reconstructions
36. Prognosis of patients undergoing hepatectomy for solitary hepatocellular carcinoma originating in the caudate lobe
37. Basing Treatment Strategy for Non-functional Pancreatic Neuroendocrine Tumors on Tumor Size
38. Mucinous micropapillary pattern in lung adenocarcinomas: a unique histology with genetic correlates
39. Clinicopathological features of recurrent primary liver cancer in Japan
40. Systematic subsegmentectomy for hepatocellular carcinoma
41. Surgical Management of Infrahilar/Suprapancreatic Cholangiocarcinoma: an Analysis of the Surgical Procedures, Surgical Margins, and Survivals of 77 Patients
42. Erratum to: Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial
43. Efficacy of a Hepatectomy and a Tumor Thrombectomy for Hepatocellular Carcinoma with Tumor Thrombus Extending to the Main Portal Vein
44. Prolyl 4-Hydroxylation of α-Fibrinogen: A NOVEL PROTEIN MODIFICATION REVEALED BY PLASMA PROTEOMICS
45. Clinical Significance of Frozen Section Analysis During Resection of Intraductal Papillary Mucinous Neoplasm: Should a Positive Pancreatic Margin for Adenoma or Borderline Lesion Be Resected Additionally?
46. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement
47. Perioperative and long-term outcomes after pancreaticoduodenectomy in elderly patients 80 years of age and older
48. Is Preservation of the Remnant Stomach Safe During Distal Pancreatectomy in Patients Who Have Undergone Distal Gastrectomy?
49. Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass
50. Definition of T3/4 and Regional Lymph Nodes in Gallbladder Cancer: Which Is More Valid, the UICC or the Japanese Staging System?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.